Starget Pharma
VerifiedThis company is developing new targeted radiopharmaceutical technologies to treat solid tumors.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$40—60m (Dealroom.co estimates Dec 2021.)
Ramat Hasharon Tel Aviv District (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
* | $10.0m | Early VC | |
| Total Funding | 000k | ||